Visit https://www.peervoice.com/QPW860 to view the entire programme with slides. After completing “John K. Marshall, MD, MSc, FRCPC, AGAF, CAGF - Real-World Experience With Janus Kinase Inhibitors in the Treatment of Advanced Ulcerative Colitis: What Does the Evidence Say?”, participants will be able to: Discuss the safety and efficacy of JAK inhibitors and their real-world evidence in the treatment of advanced ulcerative colitis; and Apply strategies to tailor therapy selection for patients with advanced ulcerative colitis using JAK inhibitors.